jobs.jnj.com/en/jobs/
Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:
Switzerland
Illustration of people examining large charts and graphs alt
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
43
Latest News

What You Need to Know About Johnson & Johnson's 2022 Second-Quarter Earnings

Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
43
Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Today's Top Reads Close
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
43
expand

This morning, Johnson & Johnson shared its second-quarter performance.

Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 144,000 employees across the globe working every day to help change the trajectory of health for humanity.

"We are proud to have delivered on the robust operational guidance that we set forth at the beginning of the year, as we’ve continued to advance breakthrough innovation and foster patient access to make a positive impact across many areas of healthcare," says Joe Wolk Circular image Joe WolkExecutive Vice President and Chief Financial Officer, Johnson & Johnson, Executive Vice President and Chief Financial Officer, Johnson & Johnson. "Johnson & Johnson is strongly positioned to continue making progress on our business priorities, including the creation of the New Consumer Health Company, to deliver both near- and long-term value to all of our Credo stakeholders.”

For more details about the company's 2022 second-quarter results, and to read a message from Chief Executive Officer Joaquin Duato Circular image Joaquin DuatoChief Executive Officer, Johnson & Johnson, here's an infographic that highlights key stats.


Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
43
expand

Read the earnings press release, which includes full financial data for the second quarter of 2022.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
43

More from Johnson & Johnson

Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue